BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tierney RJ, Kao KY, Nagra JK, Rickinson AB. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains. J Virol 2011;85:12362-75. [PMID: 21957300 DOI: 10.1128/JVI.06059-11] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Yin H, Qu J, Peng Q, Gan R. Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis. Med Microbiol Immunol 2019;208:573-83. [PMID: 30386928 DOI: 10.1007/s00430-018-0570-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
2 Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. Front Oncol. 2018;8:211. [PMID: 29951372 DOI: 10.3389/fonc.2018.00211] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 16.3] [Reference Citation Analysis]
3 Tierney RJ, Nagra J, Rowe M, Bell AI, Rickinson AB. The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformation. J Virol 2015;89:2483-93. [PMID: 25540367 DOI: 10.1128/JVI.03300-14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Tycowski KT, Guo YE, Lee N, Moss WN, Vallery TK, Xie M, Steitz JA. Viral noncoding RNAs: more surprises. Genes Dev 2015;29:567-84. [PMID: 25792595 DOI: 10.1101/gad.259077.115] [Cited by in Crossref: 110] [Cited by in F6Publishing: 104] [Article Influence: 15.7] [Reference Citation Analysis]
5 Szymula A, Palermo RD, Bayoumy A, Groves IJ, Ba Abdullah M, Holder B, White RE. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome. PLoS Pathog 2018;14:e1006890. [PMID: 29462212 DOI: 10.1371/journal.ppat.1006890] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
6 Moss WN, Steitz JA. Genome-wide analyses of Epstein-Barr virus reveal conserved RNA structures and a novel stable intronic sequence RNA. BMC Genomics 2013;14:543. [PMID: 23937650 DOI: 10.1186/1471-2164-14-543] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
7 Poling BC, Price AM, Luftig MA, Cullen BR. The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis. Virology 2017;512:113-23. [PMID: 28950226 DOI: 10.1016/j.virol.2017.09.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
8 Wang C, Zhou H, Xue Y, Liang J, Narita Y, Gerdt C, Zheng AY, Jiang R, Trudeau S, Peng CW, Gewurz BE, Zhao B. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300. J Virol 2018;92:e02155-17. [PMID: 29467311 DOI: 10.1128/JVI.02155-17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Herbert A, Fedorov A, Poptsova M. Mono a Mano: ZBP1’s Love–Hate Relationship with the Kissing Virus. IJMS 2022;23:3079. [DOI: 10.3390/ijms23063079] [Reference Citation Analysis]
10 El-Sharkawy A, Al Zaidan L, Malki A. Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis. Front Oncol 2018;8:265. [PMID: 30116721 DOI: 10.3389/fonc.2018.00265] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
11 Brooks JM, Long HM, Tierney RJ, Shannon-Lowe C, Leese AM, Fitzpatrick M, Taylor GS, Rickinson AB. Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination. PLoS Pathog 2016;12:e1005549. [PMID: 27096949 DOI: 10.1371/journal.ppat.1005549] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
12 Ba Abdullah MM, Palermo RD, Palser AL, Grayson NE, Kellam P, Correia S, Szymula A, White RE. Heterogeneity of the Epstein-Barr Virus (EBV) Major Internal Repeat Reveals Evolutionary Mechanisms of EBV and a Functional Defect in the Prototype EBV Strain B95-8. J Virol 2017;91:e00920-17. [PMID: 28904201 DOI: 10.1128/JVI.00920-17] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
13 Tzellos S, Farrell PJ. Epstein-barr virus sequence variation-biology and disease. Pathogens. 2012;1:156-174. [PMID: 25436768 DOI: 10.3390/pathogens1020156] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 6.3] [Reference Citation Analysis]
14 Tierney RJ, Shannon-Lowe CD, Fitzsimmons L, Bell AI, Rowe M. Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA. Virology 2015;474:117-30. [PMID: 25463610 DOI: 10.1016/j.virol.2014.10.030] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
15 Campion EM, Hakimjavadi R, Loughran ST, Phelan S, Smith SM, D'Souza BN, Tierney RJ, Bell AI, Cahill PA, Walls D. Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis. J Virol 2014;88:5001-13. [PMID: 24554662 DOI: 10.1128/JVI.03642-13] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
16 Lee N. The many ways Epstein-Barr virus takes advantage of the RNA tool kit. RNA Biol 2021;18:759-66. [PMID: 33517840 DOI: 10.1080/15476286.2021.1875184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Murata T, Sugimoto A, Inagaki T, Yanagi Y, Watanabe T, Sato Y, Kimura H. Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation. Viruses 2021;13:2344. [PMID: 34960613 DOI: 10.3390/v13122344] [Reference Citation Analysis]
18 Fitzsimmons L, Kelly GL. EBV and Apoptosis: The Viral Master Regulator of Cell Fate? Viruses 2017;9:E339. [PMID: 29137176 DOI: 10.3390/v9110339] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
19 Moss WN, Lee N, Pimienta G, Steitz JA. RNA families in Epstein-Barr virus. RNA Biol 2014;11:10-7. [PMID: 24441309 DOI: 10.4161/rna.27488] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
20 Sanosyan A, Fayd'herbe de Maudave A, Bollore K, Zimmermann V, Foulongne V, Van de Perre P, Tuaillon E. The impact of targeting repetitive BamHI-W sequences on the sensitivity and precision of EBV DNA quantification. PLoS One 2017;12:e0183856. [PMID: 28850597 DOI: 10.1371/journal.pone.0183856] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]